InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: georgejjl post# 267854

Friday, 08/28/2020 9:24:17 PM

Friday, August 28, 2020 9:24:17 PM

Post# of 463610
Actually, not likely.

The likelihood of such a corporate announcement (positive clinical results from both the Rett syndrome and Parkinson's disease dementia trials at the same time) are not high; for any number of reasons.

However, were such an announcement made it would focus the public's and media's attention on one unique matter. A single drug successfully treated two very different central nervous system diseases. Writers and commenters would have to try to explain that. How could this happen?

Regardless of any explanation by the media, the possibility that the drug might also then provide therapeutic applications for Alzheimer's would not be so summarily dismissed (the present perception).

Finally, a subsequent media release might be published telling of positive Alzheimer's results in the then concluded trial. Completion of the Anavex clinical results trifecta. After that, think that Anavex discussion topics, here and elsewhere, might be a bit different?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News